42nd week of 2016 patent applcation highlights part 8 |
Patent application number | Title | Published |
20160303049 | NANOPARTICLE FABRICATION METHODS, SYSTEMS, AND MATERIALS FOR FABRICATING ARTIFICIAL RED BLOOD CELLS | 2016-10-20 |
20160303050 | FORMULATIONS CONTAINING DIACEREIN AND METHODS OF LOWERING BLOOD LEVELS OF URIC ACID USING THE SAME | 2016-10-20 |
20160303051 | Burst Drug Release Compositions | 2016-10-20 |
20160303052 | MODULAR PARTICLES FOR IMMUNOTHERAPY | 2016-10-20 |
20160303053 | POLYMER-COATED THERAPEUTIC NANOPARTICLES | 2016-10-20 |
20160303054 | FORMULATIONS FOR INHIBITION OF pcsk9 FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA | 2016-10-20 |
20160303055 | METHODS AND COMPOSITIONS FOR INCREASING ENERGY EXPENDITURE USING CINNAMALDEHYDE | 2016-10-20 |
20160303056 | FASTING MIMICKING DIET (FMD) AND GLUCOSE LOWERING DRUGS PROTECT NORMAL CELLS AND GENERATE CANCER SENSITIZING CONDITIONS IN RESPONSE TO STANDARD AND HIGH GLUCOSE CONDITIONS INDUCED BY RAPAMYCIN AND DEXAMETHASONE | 2016-10-20 |
20160303057 | MATERIAL AND METHODS FOR TREATING DEVELOPMENTAL DISORDERS INCLUDING COMORBID AND IDIOPATHIC AUTISM | 2016-10-20 |
20160303058 | THERAPEUTIC AND/OR PREVENTIVE AGENT COMPRISING 1-INDANSULFAMIDE DERIVATIVE FOR PAIN | 2016-10-20 |
20160303059 | E-PROSTANOID RECEPTOR, PTGER3, AS A NOVEL ANTI-DIABETIC THERAPEUTIC TARGET | 2016-10-20 |
20160303060 | Solid Solution Compositions and Use in Chronic Inflammation | 2016-10-20 |
20160303061 | COMPOSITIONS AND METHODS FOR NEUROPROTECTION AND TREATMENT OF NEURODEGENERATION | 2016-10-20 |
20160303062 | ANTIMICROBIAL COMPOSITIONS AND METHOD OF USE | 2016-10-20 |
20160303063 | ANTI-INFLAMMATORY OMEGA-3 SYNERGISTIC COMBINATIONS | 2016-10-20 |
20160303064 | OMEGA-3 FATTY ACID ARTICLES OF MANUFACTURE, AND METHODS AND APPARATUS FOR MAKING SAME | 2016-10-20 |
20160303065 | LONG-ACTING KETOPROFEN COMPOSITIONS | 2016-10-20 |
20160303066 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | 2016-10-20 |
20160303067 | AMINOCARBONYLCARBAMATE COMPOUNDS | 2016-10-20 |
20160303068 | Compositions and Methods For Treating Brain Injury and Brain Diseases | 2016-10-20 |
20160303069 | MEDICAL USE OF COMPOUND FROM GARCINIA ESCULENTA | 2016-10-20 |
20160303070 | COMPOSITION FOR AN IMMUNOMODULATION | 2016-10-20 |
20160303071 | SODIUM ASCORBATE STIMULATION OF ELASTOGENESIS | 2016-10-20 |
20160303072 | VITAMINS C AND K FOR TREATING POLYCYSTIC DISEASES | 2016-10-20 |
20160303073 | DRUG FOR PREVENTING, TREATING OR PREVENTING METASTASIS OF GIANT CELL TUMOR THAT OCCURS IN BONE OR SOFT PARTS, CHONDROSARCOMA, OR OSTEOSARCOMA, LOCAL INJECTION FOR ARTERIAL EMBOLIZATION, AND ARTIFICIAL BONE | 2016-10-20 |
20160303074 | METHODS TO MITIGATE INJURY FROM RADIATION EXPOSURE BY ADMINISTERING CXCR4 ANTAGONIST DURING DECISIVE TREATMENT WINDOW | 2016-10-20 |
20160303075 | COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN TREATING INFLAMMATORY DISEASES | 2016-10-20 |
20160303076 | NOVEL METHODS | 2016-10-20 |
20160303077 | NOVEL COMPOSITIONS | 2016-10-20 |
20160303078 | METHODS OF MODULATING VARIOUS BIOMARKERS WITH CURAXINS | 2016-10-20 |
20160303079 | USE OF INDOLYL AND IDOLINYL HYDROXAMATES FOR TREATING NEURODEGENERATIVE DISORDERS OR COGNITIVE DECICITS | 2016-10-20 |
20160303080 | COMPOSITIONS AND METHODS FOR TREATING HEMATOLOGICAL MALIGNANCIES | 2016-10-20 |
20160303081 | INHIBITORS OF BETA1-INTEGRIN AND METHODS OF USE | 2016-10-20 |
20160303082 | INDOMETHACIN ANALOGS FOR THE TREATMENT OF CASTRATE-RESISTANT PROSTATE CANCER | 2016-10-20 |
20160303083 | PHARMACEUTICAL COMPOSITIONS COMPRISING 4-[1-(2,3-DIMETHYLPHENYL)ETHYL]-3HIMIDAZOLE DERIVATIVES FOR TREATING RETINAL DISEASES | 2016-10-20 |
20160303084 | DIAZOLE LACTAMS | 2016-10-20 |
20160303085 | PHARMACEUTICAL COMPOSITION COMPRISING A RYANODINE RECEPTOR ANTAGONIST FOR FACILITATING WOUND HEALING | 2016-10-20 |
20160303086 | ANTIPARASITIC USE OF ISOXAZOLINE COMPOUNDS | 2016-10-20 |
20160303087 | Estrogen Receptor Beta Agonists for Use in Treating Mesothelioma | 2016-10-20 |
20160303088 | MODULATORS OF PHARMACOKINETIC PROPERTIES OF THERAPEUTICS | 2016-10-20 |
20160303089 | COMPOUND PERTAINING TO NEUROPOIESIS AND DRUG COMPOSITION | 2016-10-20 |
20160303090 | COMPOSITIONS AND METHODS FOR INHIBITING TUMOR GROWTH | 2016-10-20 |
20160303091 | TREATMENT OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH ANTI-PROLIFERATE AND ANTI-INFLAMMATORY DRUGS | 2016-10-20 |
20160303092 | TREATMENT OF SOLID TUMORS WITH RAPAMYCIN DERIVATIVES | 2016-10-20 |
20160303093 | RAPAMYCIN FORMULATIONS AND METHODS OF THEIR USE | 2016-10-20 |
20160303094 | PHARMACEUTICAL COMPOSITIONS COMPRISING ANTIBACTERIAL AGENTS | 2016-10-20 |
20160303095 | METHODS OF TREATING HEPATITIS B VIRUS | 2016-10-20 |
20160303096 | PHARMACEUTICAL COMPOSITIONS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL) BENZOIC ACID AND ADMINISTRATION THEREOF. | 2016-10-20 |
20160303097 | METHODS FOR TREATING AN IMPAIRMENT IN GAIT AND/OR BALANCE IN PATIENTS WITH MULTIPLE SCLEROSIS USING AN AMINOPYRIDINE | 2016-10-20 |
20160303098 | Methods of Administering Pirfenidone Therapy | 2016-10-20 |
20160303099 | METHODS OF TREATMENT | 2016-10-20 |
20160303100 | Brown Adipocyte Progenitors in Human Skeletal Muscle | 2016-10-20 |
20160303101 | PREDICTING RESPONSE TO ALVOCIDIB BY MITOCHONDRIAL PROFILING | 2016-10-20 |
20160303102 | PROCESS FOR THE PRODUCTION OF DRUG FORMULATIONS FOR ORAL ADMINISTRATION | 2016-10-20 |
20160303103 | COMPOUNDS THAT TREAT MALARIA AND PREVENT MALARIA TRANSMISSION | 2016-10-20 |
20160303104 | PHARMACEUTICAL COMPOSITIONS COMPRISING ANTIBACTERIAL AGENTS | 2016-10-20 |
20160303105 | Antiparasitic Effect of Bis[3,5-Bis(Benzylidene)-4-Oxo-1-Piperidinyl]amide Derivatives | 2016-10-20 |
20160303106 | ORAL PRODUCT | 2016-10-20 |
20160303107 | NOVEL METHODS OF TREATING A NEURODEGENERATIVE DISEASE IN A MAMMAL IN NEED THEREOF | 2016-10-20 |
20160303108 | NOVEL DOSAGE FORM AND FORMULATION OF ABEDITEROL | 2016-10-20 |
20160303109 | Crenolanib for Treating FLT3 Mutated Proliferative Disorders | 2016-10-20 |
20160303110 | METHODS OF TREATING ABNORMAL MUSCULAR ACTIVITY | 2016-10-20 |
20160303111 | METHOD OF TREATING ACTINIC KERATOSIS WITH 3.75% IMIQUIMOD CREAM | 2016-10-20 |
20160303112 | METHODS OF REMOTE MONITORING OF SELF-ADMINISTRATION OF VANOXERINE FOR TERMINATING ACUTE EPISODES OF CARDIAC ARRHYTHMIA IN MAMMALS | 2016-10-20 |
20160303113 | METHODS OF SELF-ADMINISTRATION OF VANOXERINE FOR TERMINATING ACUTE EPISODES OF CARDIAC ARRHYTHMIA IN MAMMALS | 2016-10-20 |
20160303114 | PHARMACEUTICAL COMPOSITIONS CONTAINING VANOXERINE AND P450 INHIBITORS AND METHODS OF TERMINATING ACUTE EPISODES OF CARDIAC ARRHYTHMIA, RESTORING NORMAL SINUS RHYTHM, PREVENTING RECURRENCE OF CARDIAC ARRHYTHMIA AND MAINTAINING NORMAL SINUS RYTHYM IN MAMMALS THROUGH ADMINISTRATION OF SAID COMPOSITIONS | 2016-10-20 |
20160303115 | OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES FOR THE TREATMENT OF DEPRESSIVE AND STRESS DISORDERS | 2016-10-20 |
20160303116 | TREATMENT OF MULTIPLE SCLEROSIS WITH A 1,2,4-TRIAZOLO [1,5A] PYRIDINE DERIVATIVE | 2016-10-20 |
20160303117 | CHROMONE DERIVATIVE AS A DOPAMINE D3 RECEPTOR ANTAGONIST FOR ITS USE FOR THE TREATMENT OF AUTISM SPECTRUM DISORDER | 2016-10-20 |
20160303118 | BENZENESULFONAMIDE DERIVATIVES OF QUINOXALINE, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE IN METHODS FOR TREATING CANCER | 2016-10-20 |
20160303119 | COMBINATION OF BRIMONIDINE AND TIMOLOL FOR TOPICAL OPHTHALMIC USE | 2016-10-20 |
20160303120 | Quinoline Derivatives as PDE10A Enzyme Inhibitors | 2016-10-20 |
20160303121 | HETEROARYL COMPOUNDS AND USES THEREOF | 2016-10-20 |
20160303122 | TREATMENT OF HEPATITIS B VIRAL | 2016-10-20 |
20160303123 | CHROMENE DERIVATIVES AS PHOSHOINOSITIDE 3-KINASES INHIBITORS | 2016-10-20 |
20160303124 | INHIBITORS OF IMMUNE CHECKPOINT MODULATORS AND RELATED METHODS | 2016-10-20 |
20160303125 | DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS | 2016-10-20 |
20160303126 | SERINE/THREONINE KINASE INHIBITORS | 2016-10-20 |
20160303127 | COMBINATION THERAPY WITH C-MET AND EGFR ANTAGONISTS | 2016-10-20 |
20160303128 | PREPARATION AND METHODS OF USE FOR ORTHO-ARYL 5-MEMBERED HETEROARYL-CARBOXAMIDE CONTAINING MULTI-TARGETED KINASE INHIBITORS | 2016-10-20 |
20160303129 | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES | 2016-10-20 |
20160303130 | METHODS FOR TREATING B CELL PROLIFERATIVE DISORDERS | 2016-10-20 |
20160303131 | METHOD FOR TREATMENT OF SOLID MALIGNANCIES INCLUDING ADVANCED OR METASTATIC SOLID MALIGNANCIES | 2016-10-20 |
20160303132 | PYRAZOLO [3,4-D] PYRIMIDINE DERIVATIVES USEFUL TO TREAT RESPIRATORY DISORDERS | 2016-10-20 |
20160303133 | TREATMENT OF GASTROINTESTINAL AND OTHER DISORDERS | 2016-10-20 |
20160303134 | COMBINATION OF PI3K-INHIBITORS | 2016-10-20 |
20160303135 | COMBINATION THERAPY FOR TREATING CANCER | 2016-10-20 |
20160303136 | COMBINATION OF PI3K-INHIBITORS | 2016-10-20 |
20160303137 | DUAL PI3K AND WNT PATHWAY INHIBITION AS A TREATMENT FOR CANCER | 2016-10-20 |
20160303138 | Combination Therapy Of Substituted Oxazolidinones | 2016-10-20 |
20160303139 | TARGETING PRIMARY CILIA TO TREAT GLAUCOMA | 2016-10-20 |
20160303140 | RATIONALE-BASED DESIGN OF A TARGETED THERAPY FOR CANCER | 2016-10-20 |
20160303141 | CORTEXOLONE 17alpha-PROPIONATE FOR USE IN THE TREATMENT OF SKIN WOUNDS AND/OR ATROPHIC SKIN DISORDERS | 2016-10-20 |
20160303142 | FUSIDIC ACID CREAM AND METHOD FOR THE PREPARATION THEREOF | 2016-10-20 |
20160303143 | SOLID FORM OF ABIRATERONE ACETATE | 2016-10-20 |
20160303144 | Medicinal Composition Improving Leptin Resistance | 2016-10-20 |
20160303145 | SMALL MOLECULES THAT PROMOTE SKIN REGENERATION | 2016-10-20 |
20160303146 | INHIBITION OF ISOPRENOID BIOSYNTHETIC PATHWAYS TO TREAT NEUROINFLAMMATORY DISORDERS | 2016-10-20 |
20160303147 | METHODS OF REDUCING NEPHROTOXICITY IN SUBJECTS ADMINISTERED WITH NUCLEOSIDE PHOSPHONATES | 2016-10-20 |
20160303148 | Multidrug-Resistant Gram-Positive Bacteria Antibacterial Agent and Topical Agent | 2016-10-20 |